360 A phase 1 study of an Off-the-Shelf, multi-neoantigen vector (ADXS-503) alone and in combination with pembrolizumab in subjects with metastatic non-small cell lung cancer (NSCL... by Suresh Ramalingam, Jonathan Goldman, Thomas Stinchcombe, Gregory Gerstner, Missak Haigentz, Surya Vangala, Megan Parsi, Victor Kabala, Dinesh Simkhada, Andres Gutierrez